132 related articles for article (PubMed ID: 38060036)
1. Skin biopsies of patients with Morgellon's disease show increased oncostatin M expression relative to healthy controls.
Keller JJ; Liu Y; Latour E
Arch Dermatol Res; 2023 Dec; 316(1):20. PubMed ID: 38060036
[No Abstract] [Full Text] [Related]
2. A case report highlighting the growing trend of Internet-based self-diagnosis of "Morgellon's disease".
Mortillaro G; Rodgman C; Kinzie E; Ryals S
J La State Med Soc; 2013; 165(6):334-6. PubMed ID: 25073260
[TBL] [Abstract][Full Text] [Related]
3. Formication, tactile hallucinations, delusional parasitosis, and Morgellons: Enough to make your skin crawl.
Dowben JS; Kowalski PC; Keltner NL
Perspect Psychiatr Care; 2017 Oct; 53(4):220-221. PubMed ID: 28960311
[No Abstract] [Full Text] [Related]
4. Morgellons in dermatology.
Harth W; Hermes B; Freudenmann RW
J Dtsch Dermatol Ges; 2010 Apr; 8(4):234-42. PubMed ID: 19878403
[TBL] [Abstract][Full Text] [Related]
5. The challenge of Morgellons disease: A patient with clinicopathologic correlation.
Caputo V; Bonoldi E; Citterio A; Rongioletti F
Clin Dermatol; 2022; 40(6):686-690. PubMed ID: 35905899
[TBL] [Abstract][Full Text] [Related]
6. Morgellons Disease Presenting As an Eyelid Lesion.
Sandhu RK; Steele EA
Ophthalmic Plast Reconstr Surg; 2016; 32(4):e85-7. PubMed ID: 25192328
[TBL] [Abstract][Full Text] [Related]
7. A novel missense mutation in oncostatin M receptor beta causing primary localized cutaneous amyloidosis.
Saeedi M; Ebrahim-Habibi A; Haghighi A; Zarrabi F; Amoli MM; Robati RM
Biomed Res Int; 2014; 2014():653724. PubMed ID: 25054142
[TBL] [Abstract][Full Text] [Related]
8. Delusional infestation versus Morgellons disease.
Hylwa SA; Ronkainen SD
Clin Dermatol; 2018; 36(6):714-718. PubMed ID: 30446193
[TBL] [Abstract][Full Text] [Related]
9. Disorder or delusion? Living with Morgellons disease.
Simpson L; Baier M
J Psychosoc Nurs Ment Health Serv; 2009 Aug; 47(8):36-41. PubMed ID: 19681520
[TBL] [Abstract][Full Text] [Related]
10. The Koo-Brownstone staging system as a tool to assist in the management of patients with a possible diagnosis of dermatological delusions: an experts suggestion.
Brownstone N; Koo J
J Dermatolog Treat; 2022 Dec; 33(8):3199-3201. PubMed ID: 35950783
[TBL] [Abstract][Full Text] [Related]
11. Morgellons disease etiology and therapeutic approach: a systematic review.
Beuerlein KG; Balogh EA; Feldman SR
Dermatol Online J; 2021 Aug; 27(8):. PubMed ID: 34755952
[TBL] [Abstract][Full Text] [Related]
12. Intraoral Morgellons disease or delusional parasitosis: a first case report.
Dovigi AJ
Am J Dermatopathol; 2010 Aug; 32(6):603-5. PubMed ID: 20489569
[TBL] [Abstract][Full Text] [Related]
13. Itch intensity in prurigo nodularis is closely related to dermal interleukin-31, oncostatin M, IL-31 receptor alpha and oncostatin M receptor beta.
Hashimoto T; Nattkemper LA; Kim HS; Kursewicz CD; Fowler E; Shah SM; Nanda S; Fayne RA; Paolini JF; Romanelli P; Yosipovitch G
Exp Dermatol; 2021 Jun; 30(6):804-810. PubMed ID: 33428793
[TBL] [Abstract][Full Text] [Related]
14. Exploring the association between Morgellons disease and Lyme disease: identification of Borrelia burgdorferi in Morgellons disease patients.
Middelveen MJ; Bandoski C; Burke J; Sapi E; Filush KR; Wang Y; Franco A; Mayne PJ; Stricker RB
BMC Dermatol; 2015 Feb; 15(1):1. PubMed ID: 25879673
[TBL] [Abstract][Full Text] [Related]
15. Choosing the appropriate pharmacotherapy for Morgellons disease: an expert perspective.
Balogh EA; Beuerlein KG; Feldman SR
Expert Opin Pharmacother; 2022 Apr; 23(5):527-530. PubMed ID: 35076344
[No Abstract] [Full Text] [Related]
16. History of Morgellons disease: the same name for different psychodermatologic diseases?
Ferreira BR; Roccia MG; Cardoso JC; França K; Wollina U; Lotti T; Fioranelli M
Wien Med Wochenschr; 2017 Oct; 167(Suppl 1):49-51. PubMed ID: 28299553
[TBL] [Abstract][Full Text] [Related]
17. Information, consent and treatment of patients with Morgellons disease: an ethical perspective.
Söderfeldt Y; Groß D
Am J Clin Dermatol; 2014 Apr; 15(2):71-6. PubMed ID: 24671866
[TBL] [Abstract][Full Text] [Related]
18. Oncostatin M, a muscle-secreted myokine, recovers high-glucose-induced impairment of Akt phosphorylation by Fos induction in hippocampal neuron cells.
Won Seok Hyung W; Gon Lee S; Tae Kim K; Soo Kim H
Neuroreport; 2019 Aug; 30(11):765-770. PubMed ID: 31233447
[TBL] [Abstract][Full Text] [Related]
19. Oncostatin M upregulates Livin to promote keratinocyte proliferation and survival via ERK and STAT3 signalling pathways.
Wang H; Lei L; Hu J; Li Y
Exp Physiol; 2020 Jul; 105(7):1151-1158. PubMed ID: 32359099
[TBL] [Abstract][Full Text] [Related]
20. [Morgellons, a 'socially transmitted' disease].
van der Bent SAS; Kemperman PM; Vulink NC; Hoekzema R
Ned Tijdschr Geneeskd; 2019 Nov; 163():. PubMed ID: 31750635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
